speb/financial-data huggingface dataset:
SYM income_statement (quarterly, 2025-03-31) — Operating Revenue: 549651000.00
SYM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 108380772.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 93966000.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2698000.00
SYM income_statement (quarterly, 2025-03-31) — Other Income Expense: 11714000.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 125793000.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 62714000.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 61866000.00
SYM income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 11714000.00
SYM balance_sheet (quarterly, 2025-03-31) — Other Receivables: 160248000.00
SYM balance_sheet (quarterly, 2025-03-31) — Payables: 220027000.00
SYM balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 386296000.00
SYM income_statement (quarterly, 2025-03-31) — Pretax Income: -8759000.00
SYM cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 3233000.00
SYM balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SYM cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 292000.00
SYM cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
SYM balance_sheet (quarterly, 2025-03-31) — Raw Materials: 103655000.00
SYM balance_sheet (quarterly, 2025-03-31) — Receivables: 297810000.00
SYM income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 438859000.00
SYM income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12279000.00
SYM income_statement (quarterly, 2025-03-31) — Research And Development: 57960000.00
SYM income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
SYM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1331326000.00
SYM cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
SYM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 73305000.00
SYM balance_sheet (quarterly, 2025-03-31) — Share Issued: 108380772.00
SYM income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
SYM cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 30919000.00
SYM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 205414000.00
SYM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10952000.00
SYM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SYM income_statement (quarterly, 2025-03-31) — Tax Provision: -1397000.00
SYM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.12
SYM balance_sheet (quarterly, 2025-03-31) — Total Assets: 1964185000.00
SYM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 205414000.00
SYM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 421574000.00
SYM income_statement (quarterly, 2025-03-31) — Total Expenses: 570124000.00
SYM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1542611000.00
SYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 466205000.00
SYM balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 70018000.00
SYM income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -20473000.00
SYM income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
SYM income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
SYM cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -4481000.00
SYM balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
SYM balance_sheet (quarterly, 2025-03-31) — Working Capital: 25387000.00
SYM income_statement (quarterly, 2025-06-30) — +Operating Expense: 127817000.00
SYM income_statement (quarterly, 2025-06-30) — +Total Revenue: 592121000.00
SYM balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 215624000.00
SYM balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 136237000.00
SYM balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -46359000.00
SYM balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1550610000.00
SYM income_statement (quarterly, 2025-06-30) — Basic Average Shares: 109201745.00
SYM income_statement (quarterly, 2025-06-30) — Basic EPS: -0.05
SYM cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 958002000.00
SYM cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -14867000.00
SYM balance_sheet (quarterly, 2025-06-30) — Capital Stock: 60000.00
SYM balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 777576000.00
SYM balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 777576000.00
SYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 57000.00
SYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -39100000.00
SYM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -138343000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -4407000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 12532000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Inventory: 3470000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -9449000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -296000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -143828000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Payable: -4407000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 8125000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -38466000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1389000.00
SYM cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -179055000.00
SYM cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1389000.00
SYM cash_flow (quarterly, 2025-06-30) — Changes In Cash: -177386000.00
SYM balance_sheet (quarterly, 2025-06-30) — Common Stock: 60000.00
SYM balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 210753000.00
SYM cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
SYM income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 484499000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 183690000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Assets: 1426208000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 35545000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 918097000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 918097000.00
SYM balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1317411000.00
SYM cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 14202000.00
SYM cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 14202000.00
SYM income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 109201745.00
SYM income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.05
SYM income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5913000.00
SYM income_statement (quarterly, 2025-06-30) — EBIT: -20195000.00
SYM income_statement (quarterly, 2025-06-30) — EBITDA: -5993000.00
SYM income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: -3776000.00
SYM cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 3776000.00
SYM cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 24000.00
SYM cash_flow (quarterly, 2025-06-30) — End Cash Position: 780640000.00
SYM cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 57000.00
SYM balance_sheet (quarterly, 2025-06-30) — Finished Goods: 15228000.00
SYM cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -153210000.00
SYM balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2678000.00
SYM balance_sheet (quarterly, 2025-06-30) — Goodwill: 60534000.00
SYM balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 143455000.00
SYM balance_sheet (quarterly, 2025-06-30) — Gross PPE: 119372000.00
SYM income_statement (quarterly, 2025-06-30) — Gross Profit: 107622000.00
SYM balance_sheet (quarterly, 2025-06-30) — Inventory: 138901000.00
SYM balance_sheet (quarterly, 2025-06-30) — Invested Capital: 210753000.00
SYM cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -39100000.00
SYM balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 105551000.00
SYM cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
SYM balance_sheet (quarterly, 2025-06-30) — Leases: 10574000.00
SYM balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 105551000.00
SYM balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 108798000.00
SYM balance_sheet (quarterly, 2025-06-30) — Minority Interest: 232659000.00
SYM income_statement (quarterly, 2025-06-30) — Minority Interests: 26012000.00
SYM cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
SYM cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
SYM cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -61000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income: -5913000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5913000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -31925000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5913000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5913000.00
SYM cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -45172000.00
SYM income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -31925000.00
SYM cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -24233000.00
SYM cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 57000.00
SYM balance_sheet (quarterly, 2025-06-30) — Net PPE: 73013000.00
SYM balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 67298000.00
SYM balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5044000.00
SYM balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 5044000.00
SYM income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 10368000.00
SYM income_statement (quarterly, 2025-06-30) — Normalized Income: 7012190.00
SYM cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -138343000.00
SYM cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 3715000.00
SYM income_statement (quarterly, 2025-06-30) — Operating Income: -20195000.00
SYM income_statement (quarterly, 2025-06-30) — Operating Revenue: 592121000.00
SYM balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 110252933.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 101516000.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2678000.00
SYM income_statement (quarterly, 2025-06-30) — Other Income Expense: -7910000.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 82921000.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 79184000.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 61544000.00
SYM income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 8451000.00
SYM balance_sheet (quarterly, 2025-06-30) — Other Receivables: 236433000.00
SYM balance_sheet (quarterly, 2025-06-30) — Payables: 215624000.00
SYM balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 399314000.00
SYM income_statement (quarterly, 2025-06-30) — Pretax Income: -28105000.00
SYM cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
SYM balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
SYM cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 3921000.00
SYM cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
SYM cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -24233000.00
SYM balance_sheet (quarterly, 2025-06-30) — Raw Materials: 123673000.00
SYM balance_sheet (quarterly, 2025-06-30) — Receivables: 372670000.00
SYM income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 484499000.00
SYM income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 14202000.00
SYM income_statement (quarterly, 2025-06-30) — Research And Development: 52147000.00
SYM income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 16361000.00
SYM balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1337239000.00
SYM cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
SYM income_statement (quarterly, 2025-06-30) — Selling General And Administration: 75670000.00
SYM balance_sheet (quarterly, 2025-06-30) — Share Issued: 110252933.00
SYM income_statement (quarterly, 2025-06-30) — Special Income Charges: -16361000.00
SYM cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 64046000.00
SYM balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 210753000.00
SYM balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 67298000.00
SYM income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3435810.00
SYM income_statement (quarterly, 2025-06-30) — Tax Provision: 44000.00
SYM income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
SYM balance_sheet (quarterly, 2025-06-30) — Total Assets: 1827411000.00
SYM balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 210753000.00
SYM balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 443412000.00
SYM income_statement (quarterly, 2025-06-30) — Total Expenses: 612316000.00
SYM balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1383999000.00
SYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 401203000.00
SYM balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 66588000.00
SYM income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -36556000.00
SYM income_statement (quarterly, 2025-06-30) — Total Unusual Items: -16361000.00
SYM income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -16361000.00
SYM cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
SYM balance_sheet (quarterly, 2025-06-30) — Work In Process: 0.00
SYM balance_sheet (quarterly, 2025-06-30) — Working Capital: 108797000.00
SYM income_statement (annual, 2025-09-30) — +Operating Expense: 514743000.00
SYM income_statement (quarterly, 2025-09-30) — +Operating Expense: 142372000.00
SYM income_statement (annual, 2025-09-30) — +Total Revenue: 2246922000.00
SYM income_statement (quarterly, 2025-09-30) — +Total Revenue: 618457000.00
SYM balance_sheet (annual, 2025-09-30) — Accounts Payable: 286669000.00
SYM balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 286669000.00
SYM balance_sheet (annual, 2025-09-30) — Accounts Receivable: 186705000.00
SYM balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 186705000.00
SYM balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -50311000.00
SYM balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -50311000.00
SYM balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 1564815000.00
SYM balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1564815000.00
SYM cash_flow (annual, 2025-09-30) — Amortization Cash Flow: 4525000.00
SYM cash_flow (annual, 2025-09-30) — Amortization Of Intangibles: 4525000.00
SYM income_statement (annual, 2025-09-30) — Basic Average Shares: 108670159.00
SYM income_statement (quarterly, 2025-09-30) — Basic Average Shares: 111697093.00
SYM income_statement (annual, 2025-09-30) — Basic EPS: -0.16
SYM income_statement (quarterly, 2025-09-30) — Basic EPS: -0.03
SYM cash_flow (annual, 2025-09-30) — Beginning Cash Position: 730354000.00
SYM cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 780640000.00
SYM cash_flow (annual, 2025-09-30) — Capital Expenditure: -79030000.00
SYM cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -36246000.00
SYM balance_sheet (annual, 2025-09-30) — Capital Stock: 60000.00
SYM balance_sheet (quarterly, 2025-09-30) — Capital Stock: 60000.00
SYM balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 1244993000.00
SYM balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1244993000.00
SYM balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1244993000.00
SYM balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1244993000.00
SYM cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: 668000.00
SYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1622000.00
SYM cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -350742000.00
SYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -65733000.00
SYM cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 866939000.00
SYM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 530680000.00
SYM cash_flow (annual, 2025-09-30) — Change In Account Payable: 96904000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 56360000.00
SYM cash_flow (annual, 2025-09-30) — Change In Accrued Expense: 10356000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 17969000.00
SYM cash_flow (annual, 2025-09-30) — Change In Inventory: -58876000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Inventory: -28689000.00
SYM cash_flow (annual, 2025-09-30) — Change In Other Current Assets: 8696000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 25624000.00
SYM cash_flow (annual, 2025-09-30) — Change In Other Current Liabilities: -11912000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -3024000.00
SYM cash_flow (annual, 2025-09-30) — Change In Other Working Capital: 583399000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 442529000.00
SYM cash_flow (annual, 2025-09-30) — Change In Payable: 96904000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Payable: 56360000.00
SYM cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 107260000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 74329000.00
SYM cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: 70386000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 7685000.00
SYM cash_flow (annual, 2025-09-30) — Change In Receivables: 15075000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Receivables: -50495000.00
SYM cash_flow (annual, 2025-09-30) — Change In Working Capital: 714028000.00
SYM cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 467959000.00
SYM cash_flow (annual, 2025-09-30) — Changes In Account Receivables: 15075000.00
SYM cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -50495000.00
SYM cash_flow (annual, 2025-09-30) — Changes In Cash: 516865000.00
SYM cash_flow (quarterly, 2025-09-30) — Changes In Cash: 466569000.00
SYM balance_sheet (annual, 2025-09-30) — Common Stock: 60000.00
SYM balance_sheet (quarterly, 2025-09-30) — Common Stock: 60000.00
SYM balance_sheet (annual, 2025-09-30) — Common Stock Equity: 221318000.00
SYM balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 221318000.00
SYM cash_flow (annual, 2025-09-30) — Common Stock Issuance: 0.00
SYM cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
SYM income_statement (annual, 2025-09-30) — Cost Of Revenue: 1824312000.00
SYM income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 491336000.00
SYM balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 200442000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 200442000.00
SYM balance_sheet (annual, 2025-09-30) — Current Assets: 1890328000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Assets: 1890328000.00
SYM balance_sheet (annual, 2025-09-30) — Current Deferred Assets: 20532000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 20532000.00
SYM balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 1242312000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1242312000.00
SYM balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 1242312000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1242312000.00
SYM balance_sheet (annual, 2025-09-30) — Current Liabilities: 1729423000.00
SYM balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1729423000.00
SYM cash_flow (annual, 2025-09-30) — Deferred Income Tax: -4205000.00
SYM cash_flow (annual, 2025-09-30) — Deferred Tax: -4205000.00
SYM cash_flow (annual, 2025-09-30) — Depreciation: 44129000.00
SYM cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 44129000.00
SYM cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 10003000.00
SYM cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 44129000.00
SYM cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 10003000.00
SYM income_statement (annual, 2025-09-30) — Diluted Average Shares: 108670159.00
SYM income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 111697093.00
SYM income_statement (annual, 2025-09-30) — Diluted EPS: -0.16
SYM income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.03
SYM income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: -16937000.00
SYM income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3623000.00
SYM income_statement (annual, 2025-09-30) — EBIT: -92133000.00
SYM income_statement (quarterly, 2025-09-30) — EBIT: -15251000.00
SYM income_statement (annual, 2025-09-30) — EBITDA: -48004000.00
SYM income_statement (quarterly, 2025-09-30) — EBITDA: -5248000.00
SYM income_statement (annual, 2025-09-30) — Earnings From Equity Interest Net Of Tax: -13716000.00
SYM income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: -5885000.00
SYM cash_flow (annual, 2025-09-30) — Earnings Losses From Equity Investments: 13716000.00
SYM cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 5885000.00
SYM cash_flow (annual, 2025-09-30) — Effect Of Exchange Rate Changes: -26000.00
SYM cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -16000.00
SYM cash_flow (annual, 2025-09-30) — End Cash Position: 1247193000.00
SYM cash_flow (quarterly, 2025-09-30) — End Cash Position: 1247193000.00
SYM cash_flow (annual, 2025-09-30) — Financing Cash Flow: 668000.00
SYM cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1622000.00
SYM balance_sheet (annual, 2025-09-30) — Finished Goods: 30401000.00
SYM balance_sheet (quarterly, 2025-09-30) — Finished Goods: 30401000.00
SYM cash_flow (annual, 2025-09-30) — Free Cash Flow: 787909000.00
SYM cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 494434000.00
SYM balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2695000.00
SYM balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2695000.00
SYM balance_sheet (annual, 2025-09-30) — Goodwill: 59871000.00
SYM balance_sheet (quarterly, 2025-09-30) — Goodwill: 59871000.00
SYM balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 139020000.00
SYM balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 139020000.00
SYM balance_sheet (annual, 2025-09-30) — Gross PPE: 167960000.00
SYM balance_sheet (quarterly, 2025-09-30) — Gross PPE: 167960000.00
SYM income_statement (annual, 2025-09-30) — Gross Profit: 422610000.00
SYM income_statement (quarterly, 2025-09-30) — Gross Profit: 127121000.00
SYM balance_sheet (annual, 2025-09-30) — Inventory: 164390000.00
SYM balance_sheet (quarterly, 2025-09-30) — Inventory: 164390000.00
SYM balance_sheet (annual, 2025-09-30) — Invested Capital: 221318000.00
SYM balance_sheet (quarterly, 2025-09-30) — Invested Capital: 221318000.00
SYM cash_flow (annual, 2025-09-30) — Investing Cash Flow: -350742000.00
SYM cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -65733000.00
SYM balance_sheet (annual, 2025-09-30) — Investments And Advances: 123034000.00
SYM balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 123034000.00
SYM cash_flow (annual, 2025-09-30) — Issuance Of Capital Stock: 0.00
SYM cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
SYM balance_sheet (annual, 2025-09-30) — Leases: 10641000.00
SYM balance_sheet (quarterly, 2025-09-30) — Leases: 10641000.00
SYM balance_sheet (annual, 2025-09-30) — Long Term Equity Investment: 123034000.00
SYM balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 123034000.00
SYM balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 157319000.00
SYM balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 157319000.00
SYM balance_sheet (annual, 2025-09-30) — Minority Interest: 261895000.00
SYM balance_sheet (quarterly, 2025-09-30) — Minority Interest: 261895000.00
SYM income_statement (annual, 2025-09-30) — Minority Interests: 74095000.00
SYM income_statement (quarterly, 2025-09-30) — Minority Interests: 15526000.00
SYM cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: -141831000.00
SYM cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 58169000.00
SYM cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: 0.00
SYM cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
SYM cash_flow (annual, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -33000.00
SYM cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 40000.00
SYM income_statement (annual, 2025-09-30) — Net Income: -16937000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income: -3623000.00
SYM income_statement (annual, 2025-09-30) — Net Income Common Stockholders: -16937000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3623000.00
SYM income_statement (annual, 2025-09-30) — Net Income Continuous Operations: -91032000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -19149000.00
SYM income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -16937000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3623000.00
SYM income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -16937000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3623000.00
SYM cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: -91032000.00
SYM cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -19149000.00
SYM income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: -91032000.00
SYM income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -19149000.00
SYM cash_flow (annual, 2025-09-30) — Net Investment Purchase And Sale: -129881000.00
SYM cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -87656000.00
SYM cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -4187000.00
SYM cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
SYM balance_sheet (annual, 2025-09-30) — Net PPE: 117649000.00
SYM balance_sheet (quarterly, 2025-09-30) — Net PPE: 117649000.00
SYM cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -79030000.00
SYM cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -36246000.00
SYM balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 82298000.00
SYM balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 82298000.00
SYM balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 124932000.00
SYM balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 124932000.00
SYM balance_sheet (annual, 2025-09-30) — Non Current Deferred Revenue: 124932000.00
SYM balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 124932000.00
SYM income_statement (annual, 2025-09-30) — Normalized EBITDA: -25131000.00
SYM income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1264000.00
SYM income_statement (annual, 2025-09-30) — Normalized Income: 5478540.00
SYM income_statement (quarterly, 2025-09-30) — Normalized Income: 2687745.09
SYM cash_flow (annual, 2025-09-30) — Operating Cash Flow: 866939000.00
SYM cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 530680000.00
SYM cash_flow (annual, 2025-09-30) — Operating Gains Losses: 13947000.00
SYM cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 5988000.00
SYM income_statement (annual, 2025-09-30) — Operating Income: -92133000.00
SYM income_statement (quarterly, 2025-09-30) — Operating Income: -15251000.00
SYM income_statement (annual, 2025-09-30) — Operating Revenue: 2246922000.00
SYM income_statement (quarterly, 2025-09-30) — Operating Revenue: 618457000.00
SYM balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 112635932.00
SYM balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 112635932.00
SYM balance_sheet (annual, 2025-09-30) — Other Current Assets: 92050000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 92050000.00
SYM balance_sheet (annual, 2025-09-30) — Other Equity Adjustments: -2695000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2695000.00
SYM income_statement (annual, 2025-09-30) — Other Income Expense: 13190000.00
SYM income_statement (quarterly, 2025-09-30) — Other Income Expense: 1564000.00
SYM balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 79149000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 79149000.00
SYM cash_flow (annual, 2025-09-30) — Other Non Cash Items: 3469000.00
SYM balance_sheet (annual, 2025-09-30) — Other Non Current Assets: 131166000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 131166000.00
SYM balance_sheet (annual, 2025-09-30) — Other Non Current Liabilities: 63629000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 63629000.00
SYM income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: 36063000.00
SYM income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 8076000.00
SYM balance_sheet (annual, 2025-09-30) — Other Receivables: 181658000.00
SYM balance_sheet (quarterly, 2025-09-30) — Other Receivables: 181658000.00
SYM balance_sheet (annual, 2025-09-30) — Payables: 286669000.00
SYM balance_sheet (quarterly, 2025-09-30) — Payables: 286669000.00
SYM balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 487111000.00
SYM balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 487111000.00
SYM income_statement (annual, 2025-09-30) — Pretax Income: -78943000.00
SYM income_statement (quarterly, 2025-09-30) — Pretax Income: -13687000.00
SYM cash_flow (annual, 2025-09-30) — Proceeds From Stock Option Exercised: 4855000.00
SYM cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1622000.00
SYM balance_sheet (annual, 2025-09-30) — Properties: 0.00
SYM balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
SYM cash_flow (annual, 2025-09-30) — Provisionand Write Offof Assets: 7148000.00
SYM cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 2247000.00
SYM cash_flow (annual, 2025-09-30) — Purchase Of Business: -141831000.00
SYM cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 58169000.00
SYM cash_flow (annual, 2025-09-30) — Purchase Of Investment: -129881000.00
SYM cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -87656000.00
SYM cash_flow (annual, 2025-09-30) — Purchase Of PPE: -79030000.00
SYM cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -36246000.00
SYM balance_sheet (annual, 2025-09-30) — Raw Materials: 133989000.00
SYM balance_sheet (quarterly, 2025-09-30) — Raw Materials: 133989000.00
SYM balance_sheet (annual, 2025-09-30) — Receivables: 368363000.00
SYM balance_sheet (quarterly, 2025-09-30) — Receivables: 368363000.00
SYM income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 1824312000.00
SYM income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 491336000.00
SYM income_statement (annual, 2025-09-30) — Reconciled Depreciation: 44129000.00
SYM income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 10003000.00
SYM income_statement (annual, 2025-09-30) — Research And Development: 216013000.00
SYM income_statement (quarterly, 2025-09-30) — Research And Development: 58734000.00
SYM income_statement (annual, 2025-09-30) — Restructuring And Mergern Acquisition: 22873000.00
SYM income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 6512000.00
SYM balance_sheet (annual, 2025-09-30) — Retained Earnings: -1340862000.00
SYM balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1340862000.00
SYM cash_flow (annual, 2025-09-30) — Sale Of Investment: 0.00
SYM cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
SYM income_statement (annual, 2025-09-30) — Selling General And Administration: 298730000.00
SYM income_statement (quarterly, 2025-09-30) — Selling General And Administration: 83638000.00
SYM balance_sheet (annual, 2025-09-30) — Share Issued: 112635932.00
SYM balance_sheet (quarterly, 2025-09-30) — Share Issued: 112635932.00
SYM income_statement (annual, 2025-09-30) — Special Income Charges: -22873000.00
SYM income_statement (quarterly, 2025-09-30) — Special Income Charges: -6512000.00
SYM cash_flow (annual, 2025-09-30) — Stock Based Compensation: 183936000.00
SYM cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 64368000.00
SYM balance_sheet (annual, 2025-09-30) — Stockholders Equity: 221318000.00
SYM balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 221318000.00
SYM balance_sheet (annual, 2025-09-30) — Tangible Book Value: 82298000.00
SYM balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 82298000.00
SYM income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: -457460.00
SYM income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -201254.91
SYM income_statement (annual, 2025-09-30) — Tax Provision: -1627000.00
SYM income_statement (quarterly, 2025-09-30) — Tax Provision: -423000.00
SYM income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.02
SYM income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.03
SYM balance_sheet (annual, 2025-09-30) — Total Assets: 2401197000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Assets: 2401197000.00
SYM balance_sheet (annual, 2025-09-30) — Total Capitalization: 221318000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 221318000.00
SYM balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 483213000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 483213000.00
SYM income_statement (annual, 2025-09-30) — Total Expenses: 2339055000.00
SYM income_statement (quarterly, 2025-09-30) — Total Expenses: 633708000.00
SYM balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 1917984000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1917984000.00
SYM balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 510869000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 510869000.00
SYM balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 188561000.00
SYM balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 188561000.00
SYM income_statement (annual, 2025-09-30) — Total Operating Income As Reported: -115006000.00
SYM income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -21763000.00
SYM income_statement (annual, 2025-09-30) — Total Unusual Items: -22873000.00
SYM income_statement (quarterly, 2025-09-30) — Total Unusual Items: -6512000.00
SYM income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: -22873000.00
SYM income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -6512000.00
SYM cash_flow (annual, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -4481000.00
SYM cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
SYM balance_sheet (annual, 2025-09-30) — Work In Process: 0.00
SYM balance_sheet (quarterly, 2025-09-30) — Work In Process: 0.00
SYM balance_sheet (annual, 2025-09-30) — Working Capital: 160905000.00
SYM balance_sheet (quarterly, 2025-09-30) — Working Capital: 160905000.00
SYM income_statement (quarterly, 2025-12-31) — +Operating Expense: 124225000.00
SYM income_statement (quarterly, 2025-12-31) — +Total Revenue: 629985000.00
SYM balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 266102000.00
SYM balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 107631000.00
SYM balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -55257000.00
SYM balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1997587000.00
SYM income_statement (quarterly, 2025-12-31) — Basic Average Shares: 115474119.00
SYM income_statement (quarterly, 2025-12-31) — Basic EPS: 0.02
SYM cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1247193000.00
SYM cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2052000.00
SYM balance_sheet (quarterly, 2025-12-31) — Capital Stock: 61000.00
SYM balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1819102000.00
SYM balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1819102000.00
SYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 423146000.00
SYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -40580000.00
SYM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 191540000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -23857000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 8718000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Inventory: -24122000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 2335000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -2255000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 124969000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Payable: -23857000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -15139000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -51726000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Receivables: 79090000.00
SYM cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 113152000.00
SYM cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 79090000.00
SYM cash_flow (quarterly, 2025-12-31) — Changes In Cash: 574106000.00
SYM balance_sheet (quarterly, 2025-12-31) — Common Stock: 61000.00
SYM balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 663774000.00
SYM cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 424368000.00
SYM income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 496561000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 206874000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Assets: 2458202000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 27807000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1310702000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1310702000.00
SYM balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1783678000.00
SYM cash_flow (quarterly, 2025-12-31) — Depreciation: 10092000.00
SYM cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 10092000.00
SYM cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 10092000.00
SYM income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 127870238.00
SYM income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.02
SYM income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2602000.00
SYM income_statement (quarterly, 2025-12-31) — EBIT: 9199000.00
SYM income_statement (quarterly, 2025-12-31) — EBITDA: 19291000.00
SYM income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: -5799000.00
SYM cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 5799000.00
SYM cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 8000.00
SYM cash_flow (quarterly, 2025-12-31) — End Cash Position: 1821307000.00
SYM cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 423146000.00
SYM balance_sheet (quarterly, 2025-12-31) — Finished Goods: 56547000.00
SYM cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 189488000.00
SYM balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2693000.00
SYM balance_sheet (quarterly, 2025-12-31) — Goodwill: 59871000.00
SYM balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 135247000.00
SYM balance_sheet (quarterly, 2025-12-31) — Gross PPE: 170957000.00
SYM income_statement (quarterly, 2025-12-31) — Gross Profit: 133424000.00
SYM balance_sheet (quarterly, 2025-12-31) — Inventory: 183680000.00
SYM balance_sheet (quarterly, 2025-12-31) — Invested Capital: 663774000.00
SYM cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -40580000.00
SYM balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 143523000.00
SYM cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 424368000.00
SYM balance_sheet (quarterly, 2025-12-31) — Leases: 12068000.00
SYM balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 143523000.00
SYM balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 158889000.00
SYM balance_sheet (quarterly, 2025-12-31) — Minority Interest: 296437000.00
SYM income_statement (quarterly, 2025-12-31) — Minority Interests: -10756000.00
SYM cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 424368000.00
SYM cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 27000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income: 2602000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2602000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 13358000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2602000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2602000.00
SYM cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 13358000.00
SYM income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 13358000.00
SYM cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -38528000.00
SYM cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1222000.00
SYM balance_sheet (quarterly, 2025-12-31) — Net PPE: 115700000.00
SYM cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -2052000.00
SYM balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 528527000.00
SYM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 188795000.00
SYM balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 188795000.00
SYM income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 21964000.00
SYM income_statement (quarterly, 2025-12-31) — Normalized Income: 5157388.00
SYM cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 191540000.00
SYM cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 5826000.00
SYM income_statement (quarterly, 2025-12-31) — Operating Income: 9199000.00
SYM income_statement (quarterly, 2025-12-31) — Operating Revenue: 629985000.00
SYM balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 123225754.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 70393000.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2693000.00
SYM income_statement (quarterly, 2025-12-31) — Other Income Expense: 10573000.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 75376000.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 141386000.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 61374000.00
SYM income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 13246000.00
SYM balance_sheet (quarterly, 2025-12-31) — Other Receivables: 249589000.00
SYM balance_sheet (quarterly, 2025-12-31) — Payables: 266102000.00
SYM balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 472976000.00
SYM income_statement (quarterly, 2025-12-31) — Pretax Income: 19772000.00
SYM balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SYM cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 4832000.00
SYM cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -38528000.00
SYM cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2052000.00
SYM balance_sheet (quarterly, 2025-12-31) — Raw Materials: 127133000.00
SYM balance_sheet (quarterly, 2025-12-31) — Receivables: 357220000.00
SYM income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 496561000.00
SYM income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10092000.00
SYM income_statement (quarterly, 2025-12-31) — Research And Development: 43006000.00
SYM income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 2673000.00
SYM balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1331181000.00
SYM income_statement (quarterly, 2025-12-31) — Selling General And Administration: 81219000.00
SYM balance_sheet (quarterly, 2025-12-31) — Share Issued: 123225754.00
SYM income_statement (quarterly, 2025-12-31) — Special Income Charges: -2673000.00
SYM cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 45941000.00
SYM balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 663774000.00
SYM balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 528527000.00
SYM income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -117612.00
SYM income_statement (quarterly, 2025-12-31) — Tax Provision: 615000.00
SYM income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.04
SYM balance_sheet (quarterly, 2025-12-31) — Total Assets: 2994058000.00
SYM balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 663774000.00
SYM balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 960211000.00
SYM income_statement (quarterly, 2025-12-31) — Total Expenses: 620786000.00
SYM balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2033847000.00
SYM balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 535856000.00
SYM balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 250169000.00
SYM income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 6526000.00
SYM income_statement (quarterly, 2025-12-31) — Total Unusual Items: -2673000.00
SYM income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2673000.00
SYM cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -1661000.00
SYM balance_sheet (quarterly, 2025-12-31) — Working Capital: 674524000.00
SYM income_statement (quarterly, 2026-03-31) — +Operating Expense: 143849000.00
SYM income_statement (quarterly, 2026-03-31) — +Total Revenue: 676480000.00
SYM balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 293675000.00
SYM balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 132623000.00
SYM balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -62651000.00